Haryati Ahmad Hairi1, Muhammad Zulfiqah Sadikan2*, Lidawani Lambuk3, Rohimah Mohamud3
1. Department of Biochemistry, Faculty of Medicine, Manipal University College Malaysia, Bukit Baru, 75150 Melaka, Malaysia
2. Faculty of Pharmacy and Health Sciences, University Kuala Lumpur Royal College of Medicine Perak, Jalan Greentown, 30450 Ipoh, Perak, Malaysia
3. Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
Corresponding author: Muhammad Zulfiqah Sadikan.
ABSTRACT
INTRODUCTION: Cholesterol is a lipoprotein molecule that plays a role in various physiological processes in the human body. However, excessively high cholesterol levels can lead to various health disorders, including cardiovascular diseases. Over the past few years, it has been discovered that there is also a link between cholesterol and eye disorders.
OBJECTIVE: This review investigated the relationship between ocular conditions and cholesterol in detail, outlining the potential mechanisms and manifestations of such conditions.
METHOD: A comprehensive search was conducted in Medline, Google Scholar, and PubMed for relevant studies published between 1990 and 2025.
RESULTS: Several studies have established the fact that elevated cholesterol levels can lead to the development of many ocular disorders, such as age-related macular degeneration (AMD), cataracts, and glaucoma. These conditions are characterised by degenerative changes in the retina, lens, or optic nerve which lead to defective vision or total blindness. Deposition of cholesterol in the ocular blood vessels impairs blood supply, leading to retinal vascular diseases that adversely affect nutrient delivery and waste elimination. Hypercholesterolemia results in drusen formation associated with AMD. Additionally, cholesterol imbalances cause chronic inflammation and oxidative stress (OS) in ocular tissues. Inflammation is an important mediator involved in ocular diseases and results in blood-retinal barrier disruption and activation of a few inflammatory mediators. Whereas, OS leads to the production of reactive oxygen species that cause damage to ocular cells and tissues. Key cholesterol-related pathways involved in ocular disorders include LXR signalling, ABCA1/ABCG1 transporters, the HMG-CoA reductase pathway, and oxLDL-induced TLR4/NF-κB activation. Their roles in lipid accumulation, OS, inflammation, and neovascularisation highlight their potential as targets for effective ocular therapies.
CONCLUSION: Targeting cholesterol-related pathways offers a promising avenue for the development of more precise and effective therapies for managing ocular disorders linked to lipid dysregulation.
KEYWORDS: Cholesterol, Age-related Macular Degeneration, Cataract, Glaucoma, Retinal Vascular Diseases


